Most patients safely resume their GLP-1 regimen within 48 to 72 hours post-operatively, once they've tolerated clear liquids and solid foods without nausea
Guest Episode Womens health and performance: how training, nutrition, and hormones interact across life stages Guest Episode Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards Podcast Episode Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment Guest Episode The science of resistance training, building muscle, and anabolic steroid use in bodybuilding Guest Episode A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions Guest Episode Rethinking protein needs for performance, muscle preservation, and longevity, and the mental and physical benefits of creatine supplementation and sauna use AMA Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent Guest Episode The protein debate: optimal intake, limitations of the RDA, whether high-protein intake is harmful, and how to think about processed foods AMA Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins AMA GLP-1 Agonists The Future of Treating Obesity
It's generally safer for long-term use compared to chemical lightening agents
This happens as your body and metabolism adapt to your new weight
Surprisingly, CAP values were significantly reduced in ALT responders
Even slow months still contribute to significant long-term success
